What if the Breakthrough Was Already Here?
Our team met in the nation’s capital with lawmakers, clinical researchers and advocates to discuss the ongoing research in psychedelic medicines and what the future holds for these treatments.
The conversation made one thing clear: innovation in psychiatry is accelerating, and continued collaboration across science, policy, and advocacy will be critical to expanding access to new treatment options for patients.
As we continue to forge a new era of psychiatry, conversations like these are accelerating the momentum and we’re proud to be at the forefront in advancing mental health progress for the more than 50 million people suffering from generalized anxiety disorder (GAD) and major depressive disorder (MDD).
Thank you to The Hill for hosting this event, the exceptional speakers who shared their perspectives including Rep. Jack Bergman (R-MI), John Eaton, Mary Giliberti, Matthew Strait, Stephanie Fagan, Bill Sammon, Brie Jackson, Tiffany Farchione and everyone who joined in person and online.